Physician profile
John Christopher Evans
NPI 1376620294
$28,525.38
in general payments reported to CMS, 2019-2025
14 companies · $704 in 2025
The $704 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,147 · 2020: $222 · 2021: $387 · 2022: $8,996 · 2023: $9,298 · 2024: $6,771 · 2025: $704.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $6,500 · Travel and Lodging: $5,934 · Food and Beverage: $4,339.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $6,500.00 |
| Travel and Lodging | $5,933.73 |
| Food and Beverage | $4,339.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Galvanize Therapeutics, INC | $8,400.00 | 2022 | |
| Medtronic, INC. | $7,536.21 | 2022-2025 | Micra, Cobalt Dr Mri Surescan, Plasmablade(Tm) |
| Acutus Medical, INC. | $6,606.85 | 2021-2023 | |
| Boston Scientific Corporation | $1,913.89 | 2019-2025 | Ingevity+, Emblem Mri S-Icd, Watchman Flx |
| Abbott Laboratories | $1,322.63 | 2019-2025 | Aveir, Triclip, Jot Dx |
| Medtronic Vascular, INC. | $1,080.78 | 2019 | |
| Biosense Webster, INC. | $828.52 | 2019-2025 | Carto 3 |
| Glaxosmithkline, LLC. | $381.24 | 2020-2024 | Trelegy Ellipta |
| Biotronik INC. | $245.95 | 2021-2024 | Acticor 7 Vr-T Dx |
| Medical Device Business Services, INC. | $129.02 | 2019 | |
| Acist Medical Systems, INC. | $32.56 | 2019 | |
| Lantheus Medical Imaging, INC. | $27.35 | 2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $20.38 | 2024 | Lifevest |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Evans listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.